A detailed history of Gts Securities LLC transactions in Mannkind Corp stock. As of the latest transaction made, Gts Securities LLC holds 246,000 shares of MNKD stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
246,000
Previous 240,500 2.29%
Holding current value
$1.53 Million
Previous $1.09 Million 17.91%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $41,524 - $55,673
10,253 Added 45.7%
32,689 $170,000
Q1 2024

May 15, 2024

SELL
$3.25 - $5.27 $443,183 - $718,638
-136,364 Reduced 85.87%
22,436 $101,000
Q4 2023

Feb 14, 2024

BUY
$3.34 - $4.29 $318,595 - $409,214
95,388 Added 150.43%
158,800 $578,000
Q3 2023

Nov 15, 2023

SELL
$3.91 - $5.45 $53,731 - $74,893
-13,742 Reduced 17.81%
63,412 $261,000
Q2 2023

Aug 15, 2023

BUY
$3.72 - $4.79 $287,012 - $369,567
77,154 New
77,154 $314 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.6B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.